Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder
This section will adopt a hierarchical approach, beginning with molecular-level indicators, e.g., genomics and proteomics, and progressing toward higher-order systems, including cognitive and behavioral assessments and emerging modalities such as radioligand-based imaging of synaptic density [503505]
While IV and oral NAD+ therapies can boost systemic levels, topical application offers a targeted approach delivering NAD+ precursors like niacinamide and NMN directly to the skin, where energy production, DNA repair, and antioxidant defense are most needed
Moreover, systemic perfusion containing 1,25(OH)2D or 25(OH)D delayed the development of tumors and reduced lung metastasis
10.1016/j.celrep.2014.02.036 Cell Rep